Autism, also known as Autism Spectrum Disorder (ASD), is a neurodevelopmental disorder that affects communication and social interaction in individuals.

Symptoms of autism usually appear in early childhood and can have an impact on an individual’s academic and personal life. According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 54 children in the United States have been diagnosed with autism.

Early detection and intervention can significantly improve an individual’s prognosis and quality of life. Therefore, researchers have been striving to identify biomarkers that could serve as early predictors of autism.

Recently, a team of scientists from the University of California, San Diego School of Medicine and the Ludmer Centre for Neuroinformatics and Mental Health at McGill University has discovered a new biomarker that can predict autism in infants.

What is a biomarker?

A biomarker is a measurable substance in the body that indicates normal or abnormal biological processes. In medical research, biomarkers are used to diagnose and monitor diseases, as well as to predict disease outcomes and treatment responses.

Biomarkers can be obtained from various biological samples, such as blood, urine, tissue, and cerebrospinal fluid.

The study

The study, published in JAMA Pediatrics, analyzed data from 418 infants aged 6 months to 12 months who had a high risk of autism due to having an older sibling with autism.

The infants were part of the Infant Brain Imaging Study (IBIS), a multi-site longitudinal study that aims to identify early markers of autism. The researchers used a noninvasive imaging technique called functional magnetic resonance imaging (fMRI) to measure the infants’ brain activity while they were at rest.

By analyzing the fMRI data, the researchers found that the infants who later developed autism had significantly different brain connectivity patterns at 6 months of age compared to those who did not develop autism.

Specifically, the infants who developed autism had weaker connections between the posterior cingulate cortex (PCC), a brain region involved in social cognition and self-referential processing, and other regions of the brain that are important for language, communication, and sensory processing.

The researchers then developed a machine-learning algorithm that could use these brain connectivity patterns to predict which infants would develop autism at 24 months of age with an accuracy rate of 96.7%.

This means that the algorithm correctly identified 9 out of 10 infants who later developed autism, and also correctly identified 8 out of 10 infants who did not develop autism.

Implications

The discovery of this biomarker has significant implications for early diagnosis and intervention of autism.

Current methods of diagnosing autism rely on behavioral assessments, which can be imprecise and may not detect the condition until several years after the onset of symptoms. By contrast, the fMRI biomarker identified in this study can detect brain differences in infancy, before any behavioral symptoms are present.

Related Article Is it possible to predict autism?

This early detection can allow for earlier intervention and treatment, which can improve an infant’s social and cognitive development.

For instance, behavioral interventions such as applied behavior analysis (ABA) have been shown to be effective in improving language and social skills in children with autism, but these interventions are most effective when initiated early in life.

Furthermore, early detection can reduce parental stress and anxiety, as well as improve access to educational and support services for infants and families affected by autism.

In addition, the biomarker can facilitate the development of new treatments and therapies for autism by identifying potential targets for intervention.

Limitations

Despite the promising results of this study, there are several limitations that need to be addressed in future research. Firstly, the study sample consisted of infants who had a high risk of autism due to having an older sibling with autism.

Therefore, the findings may not be generalizable to infants without a family history of autism or to different ethnic and racial groups.

Secondly, the study only assessed brain connectivity patterns at a single time point (6 months of age).

Further research is needed to determine whether these patterns change over time and whether they are specific to autism or overlap with other neurodevelopmental disorders.

Thirdly, the study used a machine-learning algorithm, which has the potential to overfit the data and may have limited generalizability to other populations and datasets.

Therefore, further studies are needed to validate the use of this biomarker in diverse populations.

Conclusion

The discovery of a new biomarker for early prediction of autism is a significant advancement in the field of autism research.

This biomarker has the potential to revolutionize early detection, intervention, and treatment for infants at high risk of autism. However, further research is needed to validate the biomarker and address its limitations.

Overall, this study provides important insights into the neurobiological basis of autism and highlights the importance of interdisciplinary research in improving the lives of individuals with autism and their families.